Role of complement in Mycobacterium avium pathogenesis: in vivo and in vitro analyses of the host response to infection in the absence of complement component C3.
We investigated the importance of the host complement system in the pathogenesis of disease mediated by the intramacrophage pathogen Mycobacterium avium. Mycobacteria opsonized with complement are efficiently ingested by macrophages through various complement receptors. Furthermore, unlike other bacteria, mycobacteria can activate both the alternative and classical complement pathways in the absence of specific antibodies. Therefore, to examine the role of complement in the mycobacterial infection process in vivo, mice deficient in complement component C3 were infected with M. avium. Surprisingly, C3-deficient mice infected intravenously with M. avium displayed no difference in bacterial burden or granulomatous response compared to wild-type control mice. C3-sufficient mice and C3-deficient mice were equally susceptible to infection by M. avium regardless of the genotype at the bcg locus, a locus known to confer susceptibility to infection with intracellular pathogens. In vitro studies using mouse bone marrow-derived macrophages resulted in significant M. avium invasion of macrophages in the absence of C3; however, the kinetics of infection were delayed compared to complement-mediated invasion. The data indicate that complement does not play an essential role in mediating M. avium infections in the mouse and suggest either that other invasion mechanisms can compensate for the absence of complement-mediated entry or that complement is not a major mycobacterial opsonin in vivo.
Bohlson
S S
SS
Department of Biology, University of Notre Dame, Notre Dame, Indiana 46617, USA.
Strasser
J A
JA
Bower
J J
JJ
Schorey
J S
JS
D000818:Animals; D000907:Antibodies, Bacterial; D000918:Antibody Specificity; D001854:Bone Marrow Cells / Q000276:immunology; D003176:Complement C3 / Q000172:deficiency*; D003170:Complement Pathway, Alternative; D003171:Complement Pathway, Classical; D004198:Disease Susceptibility; D006099:Granuloma / Q000209:etiology; D008099:Liver / Q000382:microbiology / Q000473:pathology; D008264:Macrophages / Q000276:immunology; D051379:Mice; D008817:Mice, Mutant Strains; D009162:Mycobacterium avium / Q000276:immunology*; D009895:Opsonin Proteins; D013154:Spleen / Q000382:microbiology; D014376:Tuberculosis / Q000209:etiology* / Q000276:immunology*; D014409:Tumor Necrosis Factor-alpha / Q000096:biosynthesis
D000907:Antibodies, Bacterial; D003176:Complement C3; D009895:Opsonin Proteins; D014409:Tumor Necrosis Factor-alpha